Received Jun 29, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RAB | RABIES (RABAVERT) | NOVARTIS VACCINES AND DIAGNOSTICS | 2 | Unknown | IM |
The patient administered second dose of Rabavert vaccine on day ten; Case reference number US-BN-2025-00138 is a spontaneous case initially received from a pharmacist via agency (reference number: USBAV25-1969) on 08-Aug-2025 and concerns a patient of unspecified age and gender. The patient's medical history and concomitant medication details were not provided. On an unspecified date, on day zero, the patient received the first dose of RabAvert along with its constituent parts: prefilled syringe, needle for injection and needle for reconstitution (batch number: unknown) at 1 ml, intramuscularly, at unknown site of administration for Rabies pre-exposure prophylaxis. On 08-Aug-2025, on day ten, the patient received the second dose of RabAvert along with its constituent parts: prefilled syringe, needle for injection and needle for reconstitution (batch number: unknown) at 1 ml, intramuscularly, at unknown site of administration (explicitly coded as inappropriate schedule of vaccine administered'). At the time of the initial report, the patient did not experience any adverse event due to RabAvert. No further information was provided.; Reporter's Comments: This case concerns a patient of unspecified age and gender, who had received the second dose of RabAvert vaccine for an indication of rabies pre-exposure prophylaxis, on day 10, after the first dose of RabAvert, which is considered as inappropriate schedule of vaccine administered. Inappropriate schedule of vaccine administered is considered as listed per company convention. At the time of the initial report, the patient did not experience any adverse event due to RabAvert vaccine. The patient's relevant medical history and concomitant medication details were not provided. Inappropriate schedule of vaccine administered is not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.; Sender's Comments: This case concerns a patient of unspecified age and gender, who had received the second dose of RabAvert vaccine for an indication of rabies pre-exposure prophylaxis, on day 10, after the first dose of RabAvert, which is considered as inappropriate schedule of vaccine administered. Inappropriate schedule of vaccine administered is considered as listed per company convention. At the time of the initial report, the patient did not experience any adverse event due to RabAvert vaccine. The patient's relevant medical history and concomitant medication details were not provided. Inappropriate schedule of vaccine administered is not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.
Comments: None.